文献速递肺栓塞与肺血管病

成人起病特发性外周肺动脉狭窄的疾病特征

Adult-onset idiopathic peripheral pulmonary artery stenosis.
PubMed 文献 · Eur Respir J · 2023-12-21

本研究在日本20家中心纳入44例经肺动脉造影确诊、排除慢性血栓栓塞性肺高血压及大动脉炎的成人起病特发性外周肺动脉狭窄患者,收集体循环及影像与治疗资料。患者基线存在严重肺高血压,接受PAH药物及经导管肺动脉成形术后,平均肺动脉压与肺血管阻力显著改善。

要点

  • 成人起病特发性外周肺动脉狭窄常累及段级及外周肺动脉。
  • 基线肺高血压严重,但PAH药物联合经导管肺动脉成形术治疗反应良好。
  • 10年生存率低于5年及3年生存率,需长期随访。

核心结论

  • 成人起病特发性外周肺动脉狭窄表现为段级和外周肺动脉狭窄,基线肺高血压严重,但对PAH药物联合经导管肺动脉成形术治疗反应良好。

研究设计与样本

  • 日本多中心队列研究,纳入经肺动脉造影确诊的成人起病特发性外周肺动脉狭窄患者44例,排除慢性血栓栓塞性肺高血压和大动脉炎。
  • 收集患者背景、右心导管检查、影像学及治疗资料。

主要发现

  • 44例患者中位年龄39(29-57)岁,女性29例(65.9%)。
  • 肺动脉造影显示段级肺动脉狭窄41例(93.2%),外周肺动脉狭窄36例(81.8%)。
  • 35例(79.5%)接受PAH获批药物,22例(50.0%)接受联合治疗,25例(56.8%)接受经导管肺动脉成形术。
  • 右心导管显示平均肺动脉压由44降至40 mmHg(p<0.001),肺血管阻力由760降至514 dyn·s·cm⁻⁵(p<0.001)。
  • 3年、5年、10年生存率分别为97.5%(95% CI 83.5-99.6%)、89.0%(95% CI 68.9-96.4%)、67.0%(95% CI 41.4-83.3%)。

临床怎么用

  • 对成人起病特发性外周肺动脉狭窄患者,可考虑PAH药物联合经导管肺动脉成形术治疗并长期随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Peripheral pulmonary artery stenosis (PPS) refers to stenosis of the pulmonary artery from the trunk to the peripheral arteries. Although paediatric PPS is well described, the clinical characteristics of adult-onset idiopathic PPS have not been established. Our objectives in this study were to characterise the disease profile of adult-onset PPS. METHODS: We collected data in Japanese centres. This cohort included patients who underwent pulmonary angiography (PAG) and excluded patients with chronic thromboembolic pulmonary hypertension or Takayasu arteritis. Patient backgrounds, right heart catheterisation (RHC) findings, imaging findings and treatment profiles were collected. RESULTS: 44 patients (median (interquartile range) age 39 (29-57) years; 29 females (65.9%)) with PPS were enrolled from 20 centres. In PAG, stenosis of segmental and peripheral pulmonary arteries was observed in 41 (93.2%) and 36 patients (81.8%), respectively. 35 patients (79.5%) received medications approved for pulmonary arterial hypertension (PAH) and 22 patients (50.0%) received combination therapy. 25 patients (56.8%) underwent transcatheter pulmonary angioplasty. RHC data showed improvements in both mean pulmonary arterial pressure (44 versus 40 mmHg; p<0.001) and pulmonary vascular resistance (760 versus 514 dyn·s·cm-5; p<0.001) from baseline to final follow-up. The 3-, 5- and 10-year survival rates of patients with PPS were 97.5% (95% CI 83.5-99.6%), 89.0% (95% CI 68.9-96.4%) and 67.0% (95% CI 41.4-83.3%), respectively. CONCLUSIONS: In this study, patients with adult-onset idiopathic PPS presented with segmental and peripheral pulmonary artery stenosis. Although patients had severe pulmonary hypertension at baseline, they showed a favourable treatment response to PAH drugs combined with transcatheter pulmonary angioplasty.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Tamura Y, Tamura Y, Shigeta A, et al. Adult-onset idiopathic peripheral pulmonary artery stenosis. Eur Respir J. 2023. PMID: 38061784. doi:10.1183/13993003.00763-2023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。